| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/04/2006 | WO2006025053A3 Methods and kits for the detection of biotoxis and antibiotic residues |
| 05/04/2006 | WO2006023231A3 Fluorescent metal ion indicators with large stokes shift |
| 05/04/2006 | WO2006023209A3 Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases |
| 05/04/2006 | WO2006023123A3 Aptamer-functionalized electrochemical sensors and methods of fabricating and using the same |
| 05/04/2006 | WO2006017748A3 Materials and methods for identifying anti-schizophrenic agents |
| 05/04/2006 | WO2006017715A3 Methods of determining immunoresistance to botulinum toxin a |
| 05/04/2006 | WO2006008775A3 Method for identifying agents modulating the metabolism of steroid molecules and agents identified by the method |
| 05/04/2006 | WO2006008654A3 Rna dependent rna polymerases/primases from coronavirus and their use in molecular biology and drug screening |
| 05/04/2006 | WO2006006172A3 Use of anti-amyloid agents for treating and typing pathogen infections |
| 05/04/2006 | WO2006005461A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 27 (gpr27) |
| 05/04/2006 | WO2006005043A3 Compositions and methods for detecting protein interactions with target dna sequences |
| 05/04/2006 | WO2006003657A3 Indicator strip and a device for automatic testing of liquids |
| 05/04/2006 | WO2006003488A3 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 05/04/2006 | WO2006000719A3 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 05/04/2006 | WO2006000107A3 Fibre monitoring apparatus and method |
| 05/04/2006 | WO2005124356A3 Use of protein cbp2 as a marker for colorectal cancer |
| 05/04/2006 | WO2005120620A3 Durable hydrophilic mouldable polymer composition, aqueous fluid channels based on said composition, microfluidic system incorporating said channels and method for the production thereof |
| 05/04/2006 | WO2005117950A3 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity |
| 05/04/2006 | WO2005116069A3 Taste receptors of the t1r family from domestic dog |
| 05/04/2006 | WO2005114221A8 Compositions and methods for quantification of serum glycoproteins |
| 05/04/2006 | WO2005114202A3 Method for diagnosis of prostate cancer |
| 05/04/2006 | WO2005113805A3 Assays for the identification of modulators of mhc class ii expression |
| 05/04/2006 | WO2005110035A3 Monitoring systems and methods for fluid testing |
| 05/04/2006 | WO2005109002A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | WO2005103301A3 Corn event mir604 |
| 05/04/2006 | WO2005101006A3 Diagnostics and therapeutics for diseases associated with retinoid x receptor beta (rxrb) |
| 05/04/2006 | WO2005100993A3 Smart combinatorial operando spectroscopy catalytic system |
| 05/04/2006 | WO2005089524A3 Compositions and methods for detection of single molecules |
| 05/04/2006 | WO2005086827A3 Methods of assessing the need for and the effectiveness of therapy with antioxidants |
| 05/04/2006 | WO2005072097A3 Toll-like receptor 9 modulators |
| 05/04/2006 | WO2005053611A3 Treatment of phosphatidylinositol phospholipid disorders |
| 05/04/2006 | WO2005037204A3 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 05/04/2006 | WO2005029089A9 Method of diagnosing ovarian endometriosis using tfpi-2 protein |
| 05/04/2006 | WO2005021719A3 Libraries of recombinant chimeric proteins |
| 05/04/2006 | WO2005021709A8 Cln101 antibodies |
| 05/04/2006 | WO2004037972A3 Endogenous retrovirus up-regulated in prostate cancer |
| 05/04/2006 | WO2004005891A3 Expression profile of lung cancer |
| 05/04/2006 | WO2003097803A3 Cancer-linked gene as target for chemotherapy |
| 05/04/2006 | US20060095978 Screening assay |
| 05/04/2006 | US20060094986 Test strip container with integrated meter |
| 05/04/2006 | US20060094985 Autonomous, ambulatory analyte monitor or drug delivery device |
| 05/04/2006 | US20060094947 Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
| 05/04/2006 | US20060094868 System for cell-based screening |
| 05/04/2006 | US20060094864 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
| 05/04/2006 | US20060094863 Nucleic acid capable of hybridizing, serving as a marker for diagnosing feline nephropathy |
| 05/04/2006 | US20060094862 Specificity exchangers that redirect antibodies to a pathogen |
| 05/04/2006 | US20060094772 Method for detecting intracellular cholesterol |
| 05/04/2006 | US20060094641 Method for providing natural therapeutic agents with high therapeutic index |
| 05/04/2006 | US20060094128 Using ferrofluid subparticles to coat bovine serum albumin; for use in detection and identification viral particles in fluids |
| 05/04/2006 | US20060094125 detecting via liquid chromatography, mass spectrometry |
| 05/04/2006 | US20060094123 confirming the active intake of marijuana and its active component Delta 9-tetrahydrocannabinol (" Delta 9-THC") by detecting the amount of 11-nor- Delta 9-THC carboxylic acid ("THCA") in oral fluid at the picogram per milliliter (pg/ml) level using chromatography/mass spectrometry/mass spectrometry |
| 05/04/2006 | US20060094122 Method for determination of arginine, methylated arginines and derivatives thereof |
| 05/04/2006 | US20060094121 Method for analysing amino acids, peptides and proteins |
| 05/04/2006 | US20060094101 Mk2 interacting proteins |
| 05/04/2006 | US20060094096 Fibrous protein-immobilization systems |
| 05/04/2006 | US20060094079 Protein for blocking platelet adhesion |
| 05/04/2006 | US20060094077 Increasing bioavailability of carotenoids |
| 05/04/2006 | US20060094074 Methods for screening and therapeutic applications for kinesin modulators |
| 05/04/2006 | US20060094073 Saliva immunoassay for detection of antibodies for cardiovascular disease |
| 05/04/2006 | US20060094072 Peptide sequence tags and method of using same |
| 05/04/2006 | US20060094071 Method for enriching and tracking pathologic modified prions-proteins(prpsc) |
| 05/04/2006 | US20060094070 Screening for Candidate antifungal compounds that impair tRNA ligase enzyme (TRL1) function;contacting TRL1 with Candidate compounds, determining their interaction |
| 05/04/2006 | US20060094069 Tumour marker proteins and uses thereof |
| 05/04/2006 | US20060094068 Predictive markers in cancer therapy |
| 05/04/2006 | US20060094067 Method for the determination of characteristics and/or the classification of circulating macrophages, and analysis arrangement for carrying out said method |
| 05/04/2006 | US20060094066 Myelodysplastic syndrome, acute myeloid leukemia and chronic myeloid leukemia; detecting the level of myeloperoxidase in a body fluid |
| 05/04/2006 | US20060094065 Methods of analyzing a sample by MALDI-mass spectrometry |
| 05/04/2006 | US20060094064 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| 05/04/2006 | US20060094063 fenretinide derivatives; dry forms of age-related macular degeneration and dystrophies, geographic atrophy; complex may be detected by fluorescence resonance energy transfer |
| 05/04/2006 | US20060094061 Drug screening for inhibititors of extracellular matrix (ECM) degradation and inflammation using polypeptide and fragments, expression inhibitory agents such as antisense polynucleotide, a ribozyme, and a small interfering RNA; measuring binding affinity; arthritis; matrix metalloprotease, cathepsin |
| 05/04/2006 | US20060094060 Preparation and use of a reactive solid support surface |
| 05/04/2006 | US20060094059 Methods for identifying new drug leads and new therapeutic uses for known drugs |
| 05/04/2006 | US20060094058 Peptide sequence tags and method of using same |
| 05/04/2006 | US20060094057 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 05/04/2006 | US20060094056 Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases |
| 05/04/2006 | US20060094054 Fibulin-3 and uses thereof |
| 05/04/2006 | US20060094048 System, method, and product for multiple wavelength detection using single source excitation |
| 05/04/2006 | US20060094047 Primer for use in amplifying nucleotide sequences coding odor membrane protein |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094042 comprising combining the dye with a base and/or a detergent; for staining or labeling of organic molecules such as in electrophoresis |
| 05/04/2006 | US20060094041 Oligonucleotide and method for detecting verotoxin |
| 05/04/2006 | US20060094040 Lithographic mask design and synthesis of diverse probes on a substrate |
| 05/04/2006 | US20060094039 Diagnosis of fetal aneuploidy |
| 05/04/2006 | US20060094038 Cardiac pressure overload associated genes |
| 05/04/2006 | US20060094036 Incubating with a nucleic acid polymerase to form duplex and single-stranded nucleic acid; cleaving with FEN(5'flap-specific) nuclease to generate a signal |
| 05/04/2006 | US20060094030 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| 05/04/2006 | US20060094013 Salt-inducible kinases 2 and use thereof |
| 05/04/2006 | US20060094007 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 05/04/2006 | US20060094005 Contacting the sample solution with a dipstick to cause sample solution to move by capillary action to a capture zone of the dipstick thereby allowing target nucleic acid in the sample solution to be captured and detected at the capture zone |
| 05/04/2006 | US20060094002 Eukaryotic biosensor making use of a calcium regulated light emitting enzyme |
| 05/04/2006 | US20060094000 Destructible surfactants and uses thereof |
| 05/04/2006 | US20060093681 Method and apparatus for the administration of co |
| 05/04/2006 | US20060093617 Peptides for inducing a CTL and/or HTL response to hepatitis C virus |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/04/2006 | US20060093608 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093603 ErbB4 antagonists |
| 05/04/2006 | US20060093588 Device for bio-affinity material |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |